Skip to main content

Cardiovascular & Hematological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal will contain a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal will be essential reading for all pharmaceutical scientists involved in drug discovery and development.

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders) was previously published as Current Drug Targets - Cardiovascular & Hematological Disorders.

Publisher: Bentham Science Publishers

Volume 8, Number 1, March 2008


Immunomodulation Via Targeted Inhibition of Antigen Receptor Signal Transduction
pp. 1-6(6)
Authors: Schade, Andrew E.; Gonzalez-Stawinski, Gonzalo


Adiponectin and its Role in Cardiovascular Diseases
pp. 7-46(40)
Authors: Beltowski, Jerzy; Jamroz-Wisniewska, Anna; Widomska, Sylwia


Reduction of Myocardial Ischemia-Reperfusion Injury with Pre- and Postconditioning: Molecular Mechanisms and Therapeutic Targets
pp. 47-65(19)
Authors: Galagudza, Michael M.; Blokhin, Ilia O.; Shmonin, Aleksey A.; Mischenko, Kirill A.


Receptor Subtype Abundance as a Tool for Effective Intracellular Signalling
pp. 66-79(14)
Authors: Myslivecek, Jaromir; Novakova, Martina; Klein, Martin


Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
pp. 80-90(11)
Authors: Fairweather, DeLisa; Frisancho-Kiss, Sylvia


  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more